HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Mukai Selected Research

Seizures (Absence Seizure)

1/2018Antiepileptic Drugs Elevate Astrocytic Kir4.1 Expression in the Rat Limbic Region.
1/2017Nicotine Elicits Convulsive Seizures by Activating Amygdalar Neurons.
6/2013Expressional analysis of inwardly rectifying Kir4.1 channels in Noda epileptic rat (NER).
1/2013Expressional analysis of the astrocytic Kir4.1 channel in a pilocarpine-induced temporal lobe epilepsy model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Mukai Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 01/2003
6Neoplasm Metastasis (Metastasis)
07/2011 - 01/2003
4Seizures (Absence Seizure)
01/2018 - 01/2013
4Hypoxia (Hypoxemia)
01/2013 - 06/2009
4Pain (Aches)
01/2009 - 07/2005
4Atherosclerotic Plaque (Atheroma)
08/2008 - 09/2004
3Epilepsy (Aura)
01/2018 - 11/2016
3Atherosclerosis
10/2008 - 03/2008
2Melanoma (Melanoma, Malignant)
09/2021 - 01/2021
2Rupture
01/2021 - 08/2008
2Lung Neoplasms (Lung Cancer)
05/2019 - 12/2004
2Inflammation (Inflammations)
01/2019 - 11/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2004 - 05/2004
1Amyloidosis
01/2022
1Breast Neoplasms (Breast Cancer)
10/2020
1Adenocarcinoma of Lung
05/2019
1Brain Diseases (Brain Disorder)
12/2018
1Chronic Obstructive Pulmonary Disease (COPD)
01/2018
1Movement Disorders (Movement Disorder)
11/2016
1Tremor (Tremors)
11/2016
1Amyloid Plaque
06/2016
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2013

Drug/Important Bio-Agent (IBA)

8RadiopharmaceuticalsIBA
01/2018 - 09/2004
4Proteins (Proteins, Gene)FDA Link
01/2019 - 06/2009
4Diphosphonates (Bisphosphonates)IBA
01/2009 - 07/2005
3LipidsIBA
01/2022 - 01/2019
3Therapeutic UsesIBA
01/2022 - 11/2006
3Indium-111IBA
10/2021 - 01/2018
3PolymersIBA
10/2021 - 01/2018
3Cell Surface ReceptorsIBA
10/2008 - 11/2007
3oxidized low density lipoproteinIBA
10/2008 - 11/2007
3Peptides (Polypeptides)IBA
07/2007 - 01/2003
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2006 - 03/2003
2Amyloid (Amyloid Fibrils)IBA
01/2022 - 06/2016
2GoldIBA
10/2021 - 09/2021
2Drug CarriersIBA
10/2021 - 10/2020
2CarbonIBA
01/2021 - 05/2006
2Prostaglandins AIBA
01/2021 - 11/2014
2LDL Receptors (LDL Receptor)IBA
01/2019 - 10/2008
2Matrix Metalloproteinases (MMPs)IBA
01/2018 - 07/2007
2NicotineFDA Link
01/2017 - 11/2016
2methyllycaconitineIBA
01/2017 - 11/2016
2MecamylamineIBA
01/2017 - 11/2016
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2016 - 05/2004
2Chemokine ReceptorsIBA
03/2014 - 05/2006
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2014 - 01/2013
2Pharmaceutical PreparationsIBA
01/2013 - 08/2010
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2012 - 11/2009
2Oxygen (Dioxygen)IBA
10/2011 - 12/2006
2LectinsIBA
08/2008 - 11/2007
2EnzymesIBA
07/2007 - 08/2003
2perrhenate (rhenium oxide)IBA
01/2007 - 05/2006
2Dopamine (Intropin)FDA LinkGeneric
01/2004 - 01/2003
1SodiumIBA
01/2022
1Amyloidogenic ProteinsIBA
01/2022
1liposomal doxorubicin (Doxil)FDA Link
01/2022
1Congo RedIBA
01/2022
1amyloid enhancing factorIBA
01/2022
1thioflavin TIBA
01/2022
1AA amyloidosisIBA
01/2022
1Liposomes (Liposome)IBA
01/2022
1Sulfates (Sulfates, Inorganic)IBA
09/2021
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
09/2021
1Iodine-125IBA
01/2021
1Poly(amidoamine)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1PolyethyleneimineIBA
01/2021
1Polyglutamic Acid (Polyglutamate)IBA
01/2021
1RadonIBA
01/2021
1Dendrimers (Dendrons)IBA
01/2021
1EmulsionsIBA
10/2020
1ZincIBA
05/2019
1IonsIBA
05/2019
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2018
1SulfonamidesIBA
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018
1Pancreatic Elastase (Elastase)IBA
01/2018
1dibenzofuranIBA
01/2018
1Valproic Acid (Depakote)FDA LinkGeneric
01/2018
1Phenobarbital (Luminal)FDA Link
01/2018
1Phenytoin (Dilantin)FDA LinkGeneric
01/2018
1Ethosuximide (Zarontin)FDA LinkGeneric
01/2018
1CarbamatesIBA
01/2018
1AmidesIBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2016
1Hexamethonium (Hexamethonium Bromide)IBA
11/2016
1Heparitin Sulfate (Heparan Sulfate)IBA
06/2016
1GlycosaminoglycansIBA
06/2016
1Pentetic Acid (DTPA)FDA LinkGeneric
11/2014
1quinone (benzoquinone)IBA
11/2014
1Oxidoreductases (Dehydrogenase)IBA
11/2014
1LigandsIBA
03/2014
1pimonidazoleIBA
01/2013

Therapy/Procedure

3Therapeutics
01/2022 - 11/2006
3Radiotherapy
01/2018 - 12/2004
1Intraperitoneal Injections
01/2022
1Photothermal Therapy
09/2021
1Intravenous Injections
01/2018